Clive Long

879 total citations
17 papers, 598 citations indexed

About

Clive Long is a scholar working on Physiology, Molecular Biology and Biochemistry. According to data from OpenAlex, Clive Long has authored 17 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Molecular Biology and 4 papers in Biochemistry. Recurrent topics in Clive Long's work include Nitric Oxide and Endothelin Effects (8 papers), Protease and Inhibitor Mechanisms (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Clive Long is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Protease and Inhibitor Mechanisms (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Clive Long collaborates with scholars based in United Kingdom, United States and Australia. Clive Long's co-authors include Trevor W. Stone, Barry A. Berkowitz, M G Collis, S.M.O. Hourani, Kitty B.J.M. Cleutjens, Kenneth J. Rodgers, Marion Gijbels, Deborah J. Watkins, Sharada Karanam and Peter M. Frederik and has published in prestigious journals such as Circulation, Journal of Medicinal Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Clive Long

17 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clive Long United Kingdom 11 199 193 144 138 82 17 598
Federico Corti United States 16 182 0.9× 403 2.1× 106 0.7× 77 0.6× 50 0.6× 24 808
Nour‐Eddine Rhaleb United States 19 128 0.6× 408 2.1× 45 0.3× 207 1.5× 48 0.6× 39 963
Renata Windak Poland 6 113 0.6× 413 2.1× 164 1.1× 133 1.0× 107 1.3× 18 689
Christian Bindesbøll Norway 16 110 0.6× 480 2.5× 98 0.7× 24 0.2× 118 1.4× 23 839
Alan S. Lader United States 13 184 0.9× 551 2.9× 82 0.6× 236 1.7× 103 1.3× 23 1.1k
Mark V. Stevens United States 12 131 0.7× 571 3.0× 103 0.7× 86 0.6× 65 0.8× 17 866
Eto Y Japan 14 164 0.8× 436 2.3× 51 0.4× 176 1.3× 152 1.9× 28 795
Kaiming Xu United States 14 55 0.3× 309 1.6× 97 0.7× 33 0.2× 31 0.4× 22 589
Paraskevi Andriopoulou Greece 7 143 0.7× 461 2.4× 116 0.8× 66 0.5× 44 0.5× 8 815
Nakon Aroonsakool United States 11 57 0.3× 394 2.0× 30 0.2× 145 1.1× 78 1.0× 14 652

Countries citing papers authored by Clive Long

Since Specialization
Citations

This map shows the geographic impact of Clive Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive Long more than expected).

Fields of papers citing papers by Clive Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clive Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive Long. The network helps show where Clive Long may publish in the future.

Co-authorship network of co-authors of Clive Long

This figure shows the co-authorship network connecting the top 25 collaborators of Clive Long. A scholar is included among the top collaborators of Clive Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clive Long. Clive Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Baugh, Mark, David Jonathan Bennett, Jiaqiang Cai, et al.. (2010). 1H-Imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: Separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka. Bioorganic & Medicinal Chemistry Letters. 21(3). 932–935. 6 indexed citations
2.
Cai, Jiaqiang, Xavier Fradera, David Jonathan Bennett, et al.. (2010). 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important. Bioorganic & Medicinal Chemistry Letters. 20(15). 4507–4510. 16 indexed citations
3.
Ranković, Zoran, Jiaqiang Cai, Xavier Fradera, et al.. (2010). Dioxo-triazines as a novel series of cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1488–1490. 21 indexed citations
4.
Rissanen, Jukka P., et al.. (2008). Improved methods for testing antiresorptive compounds in human osteoclast cultures. Journal of Bone and Mineral Metabolism. 27(1). 105–109. 16 indexed citations
5.
Rodgers, Kenneth J., Deborah J. Watkins, Peter Chan, et al.. (2006). Destabilizing Role of Cathepsin S in Murine Atherosclerotic Plaques. Arteriosclerosis Thrombosis and Vascular Biology. 26(4). 851–856. 86 indexed citations
6.
Lutgens, Esther, Suzanne P. M. Lutgens, Birgit Faber, et al.. (2005). Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation. Circulation. 113(1). 98–107. 178 indexed citations
7.
Rawson, David J., Kevin N. Dack, Roger P. Dickinson, et al.. (2004). The Design and Synthesis of a Novel, Orally Active, Selective ETA Antagonist. Medicinal Chemistry Research. 13(3-4). 149–157. 3 indexed citations
8.
Dack, Kevin N., Roger P. Dickinson, Clive Long, & John Steele. (1998). Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(16). 2061–2066. 5 indexed citations
9.
10.
Hourani, S.M.O., et al.. (1994). Characterization of adenosine receptors in the rat isolated aorta. General Pharmacology The Vascular System. 25(7). 1381–1387. 60 indexed citations
11.
Long, Clive & Barry A. Berkowitz. (1989). What is the relationship between the endothelium derived relaxant factor and nitric oxide?. Life Sciences. 45(1). 1–14. 24 indexed citations
12.
Long, Clive, et al.. (1987). Anion exchange resins discriminate between nitric oxide and EDRF. European Journal of Pharmacology. 142(2). 317–318. 39 indexed citations
13.
Long, Clive, Henry M. Sarau, & Barry A. Berkowitz. (1987). The inhibition of release of endothelium‐derived relaxant factor by manoalide, a potent inhibitor of phospholipase A2. British Journal of Pharmacology. 92(4). 843–849. 6 indexed citations
14.
Long, Clive & Trevor W. Stone. (1987). Adenosine reduces agonist-induced production of inositol phosphates in rat aorta. Journal of Pharmacy and Pharmacology. 39(12). 1010–1014. 18 indexed citations
15.
Long, Clive & Trevor W. Stone. (1986). The effects of adenosine on receptor sensitivity in the rat vas deferens. European Journal of Pharmacology. 132(1). 11–19. 9 indexed citations
16.
Long, Clive & Trevor W. Stone. (1985). The Release of Endothelium-Derived Relaxant Factor Is Calcium Dependent. Journal of Vascular Research. 22(4). 205–208. 93 indexed citations
17.
Long, Clive & Trevor W. Stone. (1985). EDRF: a Ca2+ -dependent chemical moiety(ies). Trends in Pharmacological Sciences. 6. 285–285. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federico Corti Breakdown of academic impact, for papers by Nour‐Eddine Rhaleb Breakdown of academic impact, for papers by Renata Windak Breakdown of academic impact, for papers by Christian Bindesbøll Breakdown of academic impact, for papers by Alan S. Lader Breakdown of academic impact, for papers by Mark V. Stevens Breakdown of academic impact, for papers by Eto Y Breakdown of academic impact, for papers by Kaiming Xu Breakdown of academic impact, for papers by Paraskevi Andriopoulou Breakdown of academic impact, for papers by Nakon Aroonsakool
Rankless by CCL
2026